NeuroSearch
Cell and gene based drug research company to strengthen capital base
Published in Mental Health Business Week, June 4th, 2005
The strengthened capital base, together with external grants, makes it possible for NsGene to initiate two planned clinical phase 1/2 Parkinson and Alzheimer studies within the coming 18 months and also to exploit new and promising findings within the company's gene discovery program.
In the near future, it is expected that clinical studies will be initiated with NsGene's nerve growth factor Neublastin for the treatment of neuropathic pain. Neublastin is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Discovery Partners International, Inc.
Drug-discovery company reports Q1 revenues of $7.1 million - Neurogen Corporation
Drug discovery and development company announces financial results - OXIS International, Inc.
Company focusing on diseases of oxidative stress reports financial results - Psychiatric Solutions, Inc.
Behavioral health company reports 34% increase in revenue - Santhera Pharmaceuticals AG
Barbara A. Heller named CFO of neuromuscular, metabolic disease-focused company - Addiction Medicine
Admissions for drug treatment up for older adults - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
